EnLisense offers a range of biosensing solutions for non-invasive detection of blood glucose, stress, and inflammatory biomarkers in sweat, as well as detection and quantification of multiple biomarkers of cardiovascular diseases in small volumes of whole blood. Their technology is easy-to-use, reliable, and cost-effective, making it suitable for diagnostic and prognostic testing of chronic and infectious diseases in various environments. EnLisense also designs and develops clinical wearable electrochemical biosensor devices, such as IBD Aware and Corti, which attach to the body to collect raw data and translate it through an application. Founded in 2014 and based in Allen, Texas, EnLisense is a manufacturer of medical devices, biosensors, and platform technologies for tracking illness and wellness states.